Drawing for MEDA PHARMACEUTICALS

USPTO serial 77601160

MEDA PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 4038880Status 710
Filing date
Status date
Registration date
Oct 11, 2011
Examiner
CASE, LEIGH CAROLINE
Law office
TMEG LAW OFFICE 105

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MEDA PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of disorders and diseases of the brain and the nervous system, the eyes, the respiratory tract, and the skin; analgesic, anti-inflammatory, anti-allergic, neurological and cardiovascular medicine; pharmaceutical preparations for the treatment of diseases of the central nervous system; pharmaceutical preparations for the treatment of infections; pharmaceutical preparations for use in dermatologySECTION 8 - CANCELLED
010Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for treating respiratory conditionsSECTION 8 - CANCELLED
042[ Scientific research; Scientific research, namely, conducting clinical trials; Scientific research in the field of pharmaceuticals and clinical trials; Technological services, namely, design and testing for new product development; Technological services, namely, design and testing of new products for others; Industry analysis and research services, namely, pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development, pharmaceutical research services and testing; inspection or research of pharmaceuticals ]SECTION 8 - CANCELLED
044[ Providing information about health care ]SECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 22, 2022CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Oct 11, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 5, 2017NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 5, 2017C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 5, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 5, 2017E815TEAS SECTION 8 & 15 RECEIVED
Sep 5, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 13, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 13, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 11, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 11, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 9, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Sep 8, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 6, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 19, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE
Aug 19, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 3, 2011IUAFUSE AMENDMENT FILED
Aug 3, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 15, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Feb 11, 2011EX3GSOU EXTENSION 3 GRANTED
Feb 11, 2011EXT3SOU EXTENSION 3 FILED
Feb 11, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 19, 2011DOCKASSIGNED TO EXAMINER
Aug 13, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Aug 11, 2010EX2GSOU EXTENSION 2 GRANTED
Aug 11, 2010EXT2SOU EXTENSION 2 FILED
Aug 11, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 2, 2010EX1GSOU EXTENSION 1 GRANTED
Feb 2, 2010EXT1SOU EXTENSION 1 FILED
Feb 2, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 11, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2009NPUBNOTICE OF PUBLICATION
Apr 10, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 9, 2009ALIEASSIGNED TO LIE
Apr 6, 2009ALIEASSIGNED TO LIE
Apr 6, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 28, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 28, 2009DOCKASSIGNED TO EXAMINER
Oct 30, 2008NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance